| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 625 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 8.931 | 22.875 | 7.573 | 2.811 | 0 | 16.083 |
| Total Expenses - EUR | - | - | - | - | 9.519 | 72.916 | 70.020 | 73.869 | 32.318 | 43.249 |
| Gross Profit/Loss - EUR | - | - | - | - | -588 | -50.041 | -62.446 | -71.058 | -32.318 | -27.166 |
| Net Profit/Loss - EUR | - | - | - | - | -588 | -50.153 | -62.453 | -71.058 | -32.318 | -27.166 |
| Employees | - | - | - | - | 0 | 2 | 2 | 2 | 1 | 0 |
Check the financial reports for the company - Chrisal Probiotics S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 101 | 66.324 | 57.967 | 49.164 | 42.129 | 528 |
| Current Assets | - | - | - | - | 134.360 | 72.591 | 74.804 | 79.992 | 69.205 | 65.868 |
| Inventories | - | - | - | - | 0 | 45.498 | 44.517 | 43.084 | 30.400 | 30.230 |
| Receivables | - | - | - | - | 90.529 | 24.434 | 28.181 | 36.047 | 37.992 | 35.048 |
| Cash | - | - | - | - | 43.831 | 2.658 | 2.107 | 862 | 813 | 589 |
| Shareholders Funds | - | - | - | - | -546 | -50.680 | -112.009 | -183.415 | -215.176 | -241.140 |
| Social Capital | - | - | - | - | 42 | 50 | 49 | 49 | 49 | 48 |
| Debts | - | - | - | - | 135.008 | 189.758 | 244.924 | 312.571 | 326.510 | 307.535 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4686 - 4686" | |||||||||
| CAEN Financial Year |
4676
|
|||||||||
Comments - Chrisal Probiotics S.r.l.